https://ichgcp.net/zh/news/the-company-walvax-biotechnology-co-ltd-is-commencing-recruitment-for-the-clinical-study-to-evaluate-the-protective-efficacy-safety-and-immunogenicity-of-a-sars-cov-2-messenger-ribonucleic-acid-mrna-vaccine-candidate